You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

 

Online download statistics by month:

Online download statistics by month: August 2023 to July 2025

AbstractFullPdf
Aug 2023697708200
Sep 2023289293134
Oct 202318418498
Nov 202312012160
Dec 2023777942
Jan 2024868659
Feb 2024757544
Mar 202410710943
Apr 2024909260
May 2024848548
Jun 2024818055
Jul 2024747549
Aug 20246867118
Sep 2024616238
Oct 2024767953
Nov 2024626435
Dec 2024646631
Jan 2025797945
Feb 202517717762
Mar 2025929460
Apr 2025676746
May 2025707046
Jun 2025636360
Jul 2025110
Total284428761486